Literature DB >> 21094256

TRPA1 is activated by direct addition of cysteine residues to the N-hydroxysuccinyl esters of acrylic and cinnamic acids.

Laura R Sadofsky1, Andrew N Boa, Sarah A Maher, Mark A Birrell, Maria G Belvisi, Alyn H Morice.   

Abstract

The nociceptor TRPA1 is thought to be activated through covalent modification of specific cysteine residues on the N terminal of the channel. The precise mechanism of covalent modification with unsaturated carbonyl-containing compounds is unclear, therefore by examining a range of compounds which can undergo both conjugate and/or direct addition reactions we sought to further elucidate the mechanism(s) whereby TRPA1 can be activated by covalent modification. Calcium signalling was used to determine the mechanism of activation of TRPA1 expressed in HEK293 cells with a series of related compounds which were capable of either direct and/or conjugate addition processes. These results were confirmed using physiological recordings with isolated vagus nerve preparations. We found negligible channel activation with chemicals which could only react with cysteine residues via conjugate addition such as acrylamide, acrylic acid, and cinnamic acid. Compounds able to react via either conjugate or direct addition, such as acrolein, methyl vinyl ketone, mesityl oxide, acrylic acid NHS ester, cinnamaldehyde and cinnamic acid NHS ester, activated TRPA1 in a concentration dependent manner as did compounds only capable of direct addition, namely propionic acid NHS ester and hydrocinnamic acid NHS ester. These compounds failed to activate TRPV1 expressed in HEK293 cells or mock transfected HEK293 cells. For molecules capable of direct or conjugate additions, the results suggest for the first time that TRPA1 may be activated preferentially by direct addition of the thiol group of TRPA1 cysteines to the agonist carbonyl carbon of α,β-unsaturated carbonyl-containing compounds. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094256     DOI: 10.1016/j.phrs.2010.11.004

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

Review 1.  The transient receptor potential channel TRPA1: from gene to pathophysiology.

Authors:  Bernd Nilius; Giovanni Appendino; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2012-09-22       Impact factor: 3.657

2.  Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells.

Authors:  Lori M N Shimoda; Christy Park; Alexander J Stokes; Henry Halenani Gomes; Helen Turner
Journal:  Phytother Res       Date:  2012-04-04       Impact factor: 5.878

3.  TRPA1 contributes to the acute inflammatory response and mediates carrageenan-induced paw edema in the mouse.

Authors:  Lauri J Moilanen; Mirka Laavola; Meiju Kukkonen; Riku Korhonen; Tiina Leppänen; Edward D Högestätt; Peter M Zygmunt; Riina M Nieminen; Eeva Moilanen
Journal:  Sci Rep       Date:  2012-04-24       Impact factor: 4.379

4.  Anthelmintic activity of trans-cinnamaldehyde and A- and B-type proanthocyanidins derived from cinnamon (Cinnamomum verum).

Authors:  Andrew R Williams; Aina Ramsay; Tina V A Hansen; Honorata M Ropiak; Helena Mejer; Peter Nejsum; Irene Mueller-Harvey; Stig M Thamsborg
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

5.  Multimerization of Homo sapiens TRPA1 ion channel cytoplasmic domains.

Authors:  Gilbert Q Martinez; Sharona E Gordon
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 6.  Deciphering Subtype-Selective Modulations in TRPA1 Biosensor Channels.

Authors:  Daisuke Kozai; Reiko Sakaguchi; Tomohiko Ohwada; Yasuo Mori
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

7.  Human TRPM8 and TRPA1 pain channels, including a gene variant with increased sensitivity to agonists (TRPA1 R797T), exhibit differential regulation by SRC-tyrosine kinase inhibitor.

Authors:  Kevin Morgan; Laura R Sadofsky; Christopher Crow; Alyn H Morice
Journal:  Biosci Rep       Date:  2014-08-06       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.